Clinical Trial Update: Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of androgen deprivation therapy and pembrolizumab for advanced androgen receptor–positive salivary gland carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salivary Gland Carcinoma

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Manish Patel | Conditions: Salivary Gland Carcinoma | Phase 2 | Status: RECRUITING